Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay

Charlien Berghen; Maarten Albersen; Pierre Blanchard; Alberto Bossi; Alberto Briganti; Cesare Cozzarini; Karel Decaestecker; Valérie Fonteyne; Karin Haustermans; Steven Joniau; Daryl Lim Joon; Vincent Khoo; Paul L. Nguyen; Piet Ost; Geert Villeirs; Christof Vulsteke; Anthony Zietman; Gert De Meerleer

doi:10.1111/bju.14686

Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay

Charlien Berghen, Maarten Albersen, Pierre Blanchard, Alberto Bossi, Alberto Briganti, Cesare Cozzarini, Karel Decaestecker, Valérie Fonteyne, Karin Haustermans, Steven Joniau, Daryl Lim Joon, Vincent Khoo, Paul L. Nguyen, Piet Ost, Geert Villeirs, Christof Vulsteke, Anthony Zietman, Gert De Meerleer

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

3 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	35-39
Nombre de pages	5
journal	BJU International
Volume	124
Numéro de publication	1
Les DOIs	https://doi.org/10.1111/bju.14686
état	Publié - 1 juil. 2019

Accès au document

10.1111/bju.14686

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Berghen, C., Albersen, M., Blanchard, P., Bossi, A., Briganti, A., Cozzarini, C., Decaestecker, K., Fonteyne, V., Haustermans, K., Joniau, S., Lim Joon, D., Khoo, V., Nguyen, P. L., Ost, P., Villeirs, G., Vulsteke, C., Zietman, A., & De Meerleer, G. (2019). Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay. BJU International, 124(1), 35-39. https://doi.org/10.1111/bju.14686

@article{a2211329314844fb8cacc87406e0aa56,

title = "Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay",

keywords = "radiotherapy, stage I seminoma, testicular cancer",

author = "Charlien Berghen and Maarten Albersen and Pierre Blanchard and Alberto Bossi and Alberto Briganti and Cesare Cozzarini and Karel Decaestecker and Val{\'e}rie Fonteyne and Karin Haustermans and Steven Joniau and {Lim Joon}, Daryl and Vincent Khoo and Nguyen, {Paul L.} and Piet Ost and Geert Villeirs and Christof Vulsteke and Anthony Zietman and {De Meerleer}, Gert",

note = "Funding Information: Dr Berghen reports grants from Astellas, outside the submitted work. Dr Blanchard reports grants from Astellas Pharma, grants from Amgen, outside the submitted work. Dr Khoo reports personal fees and non-financial support from Accuray, personal fees and non-financial support from Astellas, personal fees and non-financial support from Bayer, non-financial support from Janssen, outside the submitted work, and Honoraria for Speakers Bureaus with Accuray, Astellas, Bayer, Ipsen, Janssen, Takeda, and Tolmar. Dr Nguyen reports personal fees from COTA, grants and personal fees from Astellas, grants and personal fees from Bayer, grants and personal fees from Janssen, personal fees from Genome DX, personal fees from Ferring, personal fees from Astellas, personal fees and other from Augmenix, personal fees from Dendreon, outside the submitted work. Dr Vulsteke reports other from Astellas, Astrazeneca, Roche, Novartis, personal fees from Novartis, Merck/MSD, Astrazeneca, Leo Pharma, Ipsen, Janssen, Astellas, grants from Roche, outside the submitted work. Dr Zietman reports a stipend from Elsevier as Editor-in-Chief International Journal of Radiation Oncology Biology Physics. The remaining authors declare that they have no conflict of interest.",

year = "2019",

month = jul,

day = "1",

doi = "10.1111/bju.14686",

language = "English",

volume = "124",

pages = "35--39",

journal = "BJU International",

issn = "1464-4096",

number = "1",

}

Berghen, C, Albersen, M, Blanchard, P, Bossi, A, Briganti, A, Cozzarini, C, Decaestecker, K, Fonteyne, V, Haustermans, K, Joniau, S, Lim Joon, D, Khoo, V, Nguyen, PL, Ost, P, Villeirs, G, Vulsteke, C, Zietman, A & De Meerleer, G 2019, 'Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay', BJU International, VOL. 124, Numéro 1, p. 35-39. https://doi.org/10.1111/bju.14686

TY - JOUR

T1 - Readressing the rationale of irradiation in stage I seminoma guidelines

T2 - a critical essay

AU - Berghen, Charlien

AU - Albersen, Maarten

AU - Blanchard, Pierre

AU - Bossi, Alberto

AU - Briganti, Alberto

AU - Cozzarini, Cesare

AU - Decaestecker, Karel

AU - Fonteyne, Valérie

AU - Haustermans, Karin

AU - Joniau, Steven

AU - Lim Joon, Daryl

AU - Khoo, Vincent

AU - Nguyen, Paul L.

AU - Ost, Piet

AU - Villeirs, Geert

AU - Vulsteke, Christof

AU - Zietman, Anthony

AU - De Meerleer, Gert

N1 - Funding Information: Dr Berghen reports grants from Astellas, outside the submitted work. Dr Blanchard reports grants from Astellas Pharma, grants from Amgen, outside the submitted work. Dr Khoo reports personal fees and non-financial support from Accuray, personal fees and non-financial support from Astellas, personal fees and non-financial support from Bayer, non-financial support from Janssen, outside the submitted work, and Honoraria for Speakers Bureaus with Accuray, Astellas, Bayer, Ipsen, Janssen, Takeda, and Tolmar. Dr Nguyen reports personal fees from COTA, grants and personal fees from Astellas, grants and personal fees from Bayer, grants and personal fees from Janssen, personal fees from Genome DX, personal fees from Ferring, personal fees from Astellas, personal fees and other from Augmenix, personal fees from Dendreon, outside the submitted work. Dr Vulsteke reports other from Astellas, Astrazeneca, Roche, Novartis, personal fees from Novartis, Merck/MSD, Astrazeneca, Leo Pharma, Ipsen, Janssen, Astellas, grants from Roche, outside the submitted work. Dr Zietman reports a stipend from Elsevier as Editor-in-Chief International Journal of Radiation Oncology Biology Physics. The remaining authors declare that they have no conflict of interest.

PY - 2019/7/1

Y1 - 2019/7/1

KW - radiotherapy

KW - stage I seminoma

KW - testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=85061839211&partnerID=8YFLogxK

U2 - 10.1111/bju.14686

DO - 10.1111/bju.14686

M3 - Review article

C2 - 30680874

AN - SCOPUS:85061839211

SN - 1464-4096

VL - 124

SP - 35

EP - 39

JO - BJU International

JF - BJU International

IS - 1

ER -